mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
1e-13 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
2e-10 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-10 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-07 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-07 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-07 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-07 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-07 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-07 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-06 |